Nextgen Biomed Ltd
Tel Aviv Stock Exchange NXGN.TA
Nextgen Biomed Ltd Market Capitalization on January 14, 2025: USD 1.41 M
Nextgen Biomed Ltd Market Capitalization is USD 1.41 M on January 14, 2025, a -51.06% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Nextgen Biomed Ltd 52-week high Market Capitalization is USD 2.87 M on January 15, 2024, which is 104.32% above the current Market Capitalization.
-
Nextgen Biomed Ltd 52-week low Market Capitalization is USD 1.11 M on January 02, 2025, which is -20.82% below the current Market Capitalization.
-
Nextgen Biomed Ltd average Market Capitalization for the last 52 weeks is USD 1.79 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA
| CEO | Mr. Harel Hershtik |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | 132 Azrieli Towers Round Building |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email